EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort

EPM2A encodes a dual specificity phosphatase and has been proven to be a potential biomarker in several cancers but has not been mentioned in prostate cancer (PCA). We investigated the prognostic and therapeutic value of EPM2A in PCA. The TCGA-PRAD cohort was collected to evaluate the differential e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Qintao, Li, Jiawei, Tao, Junyue, Gao, Rui, Jin, Chen, Zhou, Jun, Zhang, Meng, Hao, Zongyao, Meng, Jialin, Liang, Chaozhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527317/
https://www.ncbi.nlm.nih.gov/pubmed/36199693
http://dx.doi.org/10.3389/fphar.2022.946637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527317/
https://www.ncbi.nlm.nih.gov/pubmed/36199693
http://dx.doi.org/10.3389/fphar.2022.946637

Ejemplares similares